Post-IPO Equity - Interleukin Genetics - Jul 2, 2012 Funding Round Profile - Cointime

Bitcoin $91,130.32 -4.03%
Ethereum $3,315.89 -4.60%
BNB $611.81 -4.81%
Optimism $2.19 -7.10%
Arbitrum $0.86 -8.59%
Solana $229.87 -3.95%
Polygon $0.52 -9.46%
Cosmos $7.90 -2.42%
Avalanche $41.72 -2.28%

Bitcoin $91,130.32 -4.03%
Ethereum $3,315.89 -4.60%
BNB $611.81 -4.81%
Optimism $2.19 -7.10%
Arbitrum $0.86 -8.59%
Solana $229.87 -3.95%
Polygon $0.52 -9.46%
Cosmos $7.90 -2.42%
Avalanche $41.72 -2.28%

Interleukin Genetics

company

Funding Round

Post-IPO Equity

Money Raised

$ 3M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Delta Dental of Oklahoma	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 17, 2006	Post-IPO Equity	$ 30M	Alticor Corporate Enterprises	Detail
Sep 1, 1997	Series Unknown	$ 1.46M		Detail
Oct 6, 1997	Debt Financing	$ 1.78M		Detail
Jan 1, 1997	Series Unknown	$ 699.99K		Detail
Jan 10, 2003	IPO	$ 16.20M		Detail